439 reported that in NSCLC, the transcriptional co-activator MRTF-A (myocardin-related transcription factor-A), interacts with NF-B/p65 rather than its common binding partner SRF (serum response factor)
This vascular mechanism may help explain why GLP-1RAs consistently show reduced dementia incidence in large observational cohorts, even when effects on amyloid burden or short-term cognition are modest [13,14,15]
A whole slew of next-generation obesity drugs are on the horizon, some already advanced enough in clinical trials to be looking as good asif not better thanthose already on the market
Together, these factors may contribute to a gut ecosystem better equipped to support your body's natural metabolic signaling
Hypoglycaemia is associated with many symptoms (Table 2) but is sometimes not perceived or experienced by the patient, including lack of early warning symptoms
Figure 1 4 Metabolic disorders and IBD The prevalence of metabolic disorders, including DM2 and obesity, is increasingly rising in the IBD population